Barnes Group Total Cost of Revenue increased by 0.5% to $259.40M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from $253.49M to $259.40M. Over 2 years (FY 2021 to FY 2023), Total Cost of Revenue shows an upward trend with a 12.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $203.17M | $205.08M | $200.91M | $207.19M | $212.75M | $208.65M | $211.40M | $226.24M | $224.63M | $253.49M | $304.43M | $300.10M | $258.19M | $259.40M |
| QoQ Change | — | +0.9% | -2.0% | +3.1% | +2.7% | -1.9% | +1.3% | +7.0% | -0.7% | +12.9% | +20.1% | -1.4% | -14.0% | +0.5% |
| YoY Change | — | — | — | — | +4.7% | +1.7% | +5.2% | +9.2% | +5.6% | +21.5% | +44.0% | +32.6% | +14.9% | +2.3% |